ACannabis 2024 Resources

ACannabis 2024

The theme for ACannabis 2024 was Innovate, Collaborate Grow. Dive back in to any session with our video library.

Session List – Day 1

Session List – Day 2

Speaker Presentations – Day 1

Session 1 – Opening & Welcome

Peter Koetsier, Chair, MCIA
The Hon Ged Kearney MP, Assistant Minister for Health and Aged Care

Australian Medicinal Cannabis Market Landscape Past, Present and Future: What are the Trends

Session 2 – Presentations and Panel Discussion

A deep dive into:

  • Market Data including TGA, TGA FOI and NostraData
  • Products available in Australia

Moderator:

  • Cassandra Hunt, Industry Advisor

Speakers:

  • Rhys Cohen, Policy Officer, Penington Institute
  • Tom Brown, Co-founder, Honahlee
  • Sharon Miller, Proprietor/Consultant Pharmacist, MediGreen Dispensary and Clinic

Session 2 Downloads (PDF)
Deep Dive in to Market Data and Products available in Australia – Rhys Cohen
The Australian Medicinal Cannabis Market Trends – Tom Brown

Session 3 – Presentation and Panel Discussion

A deep dive into:

  • Patients – patient profiles and indications being prescribed
  • Production Pathways – from origin to patients

Moderator:

  • Clare Barker, Industry Expert

Panelists:

  • Barry Cox, General Manager, Steritech
  • Phoebe Macleod, Managing Director, Heyday Medical
  • Rhys Staley, Vice President, Montu

Session 3 Download (PDF)
Patients and Production Pathways – Phoebe Macleod

Australian Regulatory & Legislative Landscape

Session 4 – In Conversation with the Australian Regulators

Discussions and updates on ODC and TGA activity in the medicinal cannabis space
Followed by Q & A

Moderator:

  • Clare Barker, Industry Expert

Presenters:

  • Chris Bedford, First Assistant Secretary, Regulatory Practice and Support Division, HPRG
  • Avi Rebera, Assistant Secretary, Office of Drug Control
  • Prof Robyn Langham, Chief Medical Advisor, TGA

Session 4 Download (PDF)
Discussions and updates on TGA activity in the medicinal cannabis space

Session 4a – TGA update: GMP and Advertising

Followed by Q & A

Presenters:

  • Hien Le, Director, Advertising and Product Investigation Section, Regulatory Compliance Branch, TGA
  • Dr Katherine Clark, Director GMP Operations and Strategy Section, Manufacturing Quality Branch, TGA

Session 4a Download (PDF)
TGA update: GMP and Advertising – Hien Le and Dr Katherine Clark

Session 5 – AHPRA’s Role in Regulating Health Practitioners

Followed by Q & A

Moderator:

  • Fiona Patten MP, Former Member of Parliament

Presenter:

  • Rachel Griffiths, Manager, Strategic Policy Australian Health Practitioner Regulation Agency
  • Tom Hall, National Manager, Notifications – Strategy and Planning, Australian Health Practitioner Regulation Agency

Session 6 – Legalisation: What is the Current State of Medicinal Cannabis Legislation

Fireside Chat

Moderator:

  • Fiona Patten MP, Former Member of Parliament

Speaker:

  • David Ettershank MP, Member for Western Metropolitan Region, Legalise Cannabis Victoria

Session 7 – Community Attitudes Toward Legislation

Moderator:

  • Fiona Patten MP, Former Member of Parliament

Presenter:

  • John Ryan, CEO, Penington Institute

Session 7 Download (PDF)
Community Attitudes Toward Legislation – John Ryan

Session 8 – Where are we today in Australia: CEO Roundtable

Panel Discussion with Industry Leaders

Moderator:

  • Shane Duncan, Industry Expert

Speakers:

  • Ean Alexander, CEO & Director, Altum
  • Tommy Huppert, CEO, Cannatrek
  • Rhys Staley, Vice President, Montu
  • Kristin Viccars, Managing Director, MedReleaf Australia

Olivia Newton-John Service to Industry Award

Recognising excellence in the medicinal cannabis industry

Presented by:

  • Peter Crock, Director, MCIA

Speaker Presentations – Day 2

Session 9 – Welcome

Peter Koetsier, Chair, MCIA
Councillor Dr Olivia Ball, Portfolio Lead for Health, Wellbeing and Belonging, City of Melbourne

International Medicinal Cannabis Market Landscape

Session 10 – Global Cannabis Markets – Trends and Opportunities

  • Key markets in terms of sales and regulatory developments

Moderators:

  • Rosemary Richards, Director, Bowman Richards & Associates
  • Cam Scadding, Founder and Managing Director, SourceCertain

Keynote Presentation

  • Deepak Anand, Principal, ASDA Consultancy Services

Session 10 Download (PDF)
Global Cannabis Update – Deepak Anand

Session 11 – Exporters Roundtable

Hot Topic:

  • Israel’s anti-dumping investigation (Canada)

Panelists:

  • Deepak Anand, Principal, ASDA Consultancy Services
  • Andrew Dowling, Lawyer & Co-Founder, AltMed
  • James Gaskell, Chief Operating Office, The Australian Natural Therapeutics Group
  • Paul Long, CEO, Little Green Pharma
  • Nan-Maree Schoerie, Managing Director, ECS Botanics

Session 12 – New Horizons: Putting the Australian Medicinal Cannabis Industry on the Global Stage

Presentation and Panel Discussion

  • Australian medicinal cannabis industry strategic export roadmap
  • Navigating export markets and where Australia should focus

Presenter:

  • Rosemary Richards, Director, Bowman Richards & Associates

Panelists:

  • Deepak Anand, Principal, ASDA Consultancy Services
  • Barry Cox, General Manager, Steritech
  • Dirk Beelen, CCO, MedTEC Pharma

Session 13 – Ambition Into Action – Building Competitive Value Chains

Presentation and Panel Discussion

Presenter:

  • Cam Scadding, Founder and Managing Director, SourceCertain

Panelists:

  • Dirk Beelen, CCO, MedTEC Pharma
  • Andres Fajardo, CEO & Director, CleverLeaves
  • Kyle Hunt, CEO, Health Care Providers Association

Session 13 Download (PDF)
Ambition Into Action – Cameron Scadding

Patients at the Centre

Session 14 – Plant to Pre-Clinical Research: Overview of Pre-Clinical Trials

Moderator:

  • Peter Crock, Director, MCIA

Fireside Chat:

  • Prof Tony Bacic, Director ARC MedAg Hub
  • Dr Filippa Brugliera, Chief Scientist, Cann Group
  • Prof Iain McGregor, Psychopharmacology and Academic Director, The Lambert initiative, University of Sydney

Research Presentations:

  • Professor Ross Bathgate, Leader Neurotherapeutics Theme, The Florey Institute of Neuroscience and Mental Health
  • Associate Professor Monika Doblin, Research Director, ARC Research Hub For Medicinal Agriculture
  • Danielle McCartney, Postdoctoral Research Associate, Lambert Initiative, University of Sydney
  • Chase (Chaseley) McKenzie, PhD student, University of Melbourne and The Florey Institute
  • Ben Wee, PhD student, MedAg Hub LTU
  • Rupinder Brar, Founder & Director, Greenlab

Session 14 Research Presnetation Downloads (PDF)
The most common targets of Cannabinoids – Professor Ross Bathgate
Mitigation of Hop Latent Viroid (HLVd) in Australia using biotechnology tools – Associate Professor Monika Doblin
Does CBD Enhance Exercise Enjoyment? – Danielle McCartney
Cannabinoids and HCN1-epilepsy – Chase (Chaseley) McKenzie
Medical Cannabis New Zealand Updates – Rupinder Brar

Session 15 – Clinical Research: Overview of Medicinal Cannabis Clinical Trials

Presenter:

  • Mary Nteris, Director, Enimera RegsPlus

Session 15 Download (PDF)
Clinical Research: Overview of Medicinal Cannabis Clinical Trials – Mary Nteris

Session 16 – Prescribing for special patient populations

Moderator:

  • Martin Lane, Co-founder, Cannabiz

Panelists:

  • Dr Dev Banerjee, Sleep & Cannabinoid Physician
  • Kyle Hunt, CEO, Health Care Providers Association
  • Lisa Todd, Clinical Governance and Policy Manager, Epilepsy Action Australia
  • David Lott, Vivace Health
  • Dr Michael Mumford, Provocatus

Session 17 – Patient Journey

In Conversation with:

  • Mark Brayshaw, Managing Director, Levin Health
  • Alastair Clarkson, AFL Coach & former AFL Player
  • Damien Oliver, Australia’s Greatest Jockey of All Time

©2024 Copyright Medicinal Cannabis Industry Australia